Dr. Martens Plc (DE:3U2)
FRANKFURT:3U2
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | £ 764.90M | £ 787.60M | £ 877.10M | £ 1.00B | £ 908.30M |
| Gross Profit | £ 437.30M | £ 511.70M | £ 575.20M | £ 618.10M | £ 578.80M |
| Operating Income | £ 76.30M | £ 56.10M | £ 126.40M | £ 180.80M | £ 228.10M |
| EBITDA | £ 145.00M | £ 110.50M | £ 196.30M | £ 235.00M | £ 265.10M |
| Net Income | £ 23.80M | £ 4.50M | £ 69.20M | £ 128.90M | £ 181.20M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | £ 180.30M | £ 155.90M | £ 111.10M | £ 157.50M | £ 228.00M |
| Total Assets | £ 877.30M | £ 889.80M | £ 952.40M | £ 992.60M | £ 859.10M |
| Total Debt | £ 391.40M | £ 404.10M | £ 477.00M | £ 451.80M | £ 393.80M |
| Net Debt | £ 211.10M | £ 248.20M | £ 365.90M | £ 294.30M | £ 165.80M |
| Total Liabilities | £ 515.80M | £ 523.40M | £ 584.20M | £ 588.40M | £ 530.90M |
| Stockholders' Equity | £ 361.50M | £ 366.40M | £ 368.20M | £ 404.20M | £ 328.20M |
| Cash Flow | |||||
| Free Cash Flow | £ 116.30M | £ 177.60M | £ 139.50M | £ 25.90M | £ 159.40M |
| Operating Cash Flow | £ 125.50M | £ 196.30M | £ 167.90M | £ 77.30M | £ 184.40M |
| Investing Cash Flow | £ -11.90M | £ -15.30M | £ -25.50M | £ -50.60M | £ -25.00M |
| Financing Cash Flow | £ -86.90M | £ -134.20M | £ -185.90M | £ -99.50M | £ -47.00M |